| ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease PD James, NT Connell, B Ameer, J Di Paola, J Eikenboom, N Giraud, ... Blood advances 5 (1), 280-300, 2021 | 438 | 2021 |
| A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors G Young, RI Liesner, T Chang, R Sidonio Jr, J Oldenburg, ... Blood, The Journal of the American Society of Hematology 134 (24), 2127-2138, 2019 | 381 | 2019 |
| Rise in late onset vitamin K deficiency bleeding in young infants because of omission or refusal of prophylaxis at birth R Schulte, LC Jordan, A Morad, RP Naftel, JC Wellons III, R Sidonio Pediatric Neurology 50 (6), 564-568, 2014 | 147 | 2014 |
| A new hemophilia carrier nomenclature to define hemophilia in women and girls: communication from the SSC of the ISTH KPM van Galen, R d’Oiron, P James, R Abdul‐Kadir, PA Kouides, ... Journal of Thrombosis and Haemostasis 19 (8), 1883-1887, 2021 | 142 | 2021 |
| Effects and interferences of emicizumab, a humanised bispecific antibody mimicking activated factor VIII cofactor function, on coagulation assays JI Adamkewicz, DC Chen, I Paz-Priel Thrombosis and haemostasis 119 (07), 1084-1093, 2019 | 138 | 2019 |
| The use of an extracorporeal membrane oxygenation anticoagulation laboratory protocol is associated with decreased blood product use, decreased hemorrhagic complications, and … MS Northrop, RF Sidonio, SE Phillips, AH Smith, HC Daphne, JB Pietsch, ... Pediatric Critical Care Medicine 16 (1), 66-74, 2015 | 124 | 2015 |
| A cross‐sectional study of bleeding phenotype in haemophilia A carriers A Paroskie, D Gailani, MR DeBaun, RF Sidonio Jr British journal of haematology 170 (2), 223-228, 2015 | 122 | 2015 |
| Laboratory monitoring in emicizumab-treated persons with hemophilia A J Müller, I Pekrul, B Pötzsch, B Berning, J Oldenburg, M Spannagl Thrombosis and haemostasis 119 (09), 1384-1393, 2019 | 100 | 2019 |
| Cost-effectiveness and budget impact of emicizumab prophylaxis in haemophilia A patients with inhibitors PA Cortesi, G Castaman, G Trifirò, SS Creazzola, G Improta, G Mazzaglia, ... Thrombosis and Haemostasis 120 (02), 216-228, 2020 | 96 | 2020 |
| Immune tolerance induction in paediatric patients with haemophilia A and inhibitors receiving emicizumab prophylaxis G Batsuli, KL Zimowski, K Tickle, SL Meeks, RF Sidonio Jr Haemophilia 25 (5), 789-796, 2019 | 86 | 2019 |
| HAVEN 2 updated analysis: multicenter, open-label, phase 3 study to evaluate efficacy, safety and pharmacokinetics of subcutaneous administration of emicizumab prophylaxis in … G Young, RF Sidonio, R Liesner, J Oldenburg, T Chang, M Uguen, ... Blood 130, 85, 2017 | 73 | 2017 |
| Late vitamin K deficiency bleeding in infants whose parents declined vitamin K prophylaxis—Tennessee, 2013 M Warren, A Miller, J Traylor, R Sidonio, A Morad, A Goodman, ... Morbidity and Mortality Weekly Report 62 (45), 901, 2013 | 70 | 2013 |
| Effect of anticoagulant therapy for 6 weeks vs 3 months on recurrence and bleeding events in patients younger than 21 years of age with provoked venous thromboembolism: the … NA Goldenberg, JM Kittelson, TC Abshire, M Bonaca, JF Casella, ... Jama 327 (2), 129-137, 2022 | 66 | 2022 |
| Emicizumab prophylaxis provides flexible and effective bleed control in children with hemophilia Α with inhibitors: results from the HAVEN 2 study G Young, R Liesner, RF Sidonio Jr, J Oldenburg, V Jimenez-Yuste, ... Blood 132, 632, 2018 | 66 | 2018 |
| Novel therapeutics for hemophilia and other bleeding disorders MU Callaghan, R Sidonio, SW Pipe Blood, The Journal of the American Society of Hematology 132 (1), 23-30, 2018 | 59 | 2018 |
| Females with FVIII and FIX deficiency have reduced joint range of motion RF Sidonio, FD Mili, T Li, CH Miller, WC Hooper, MR DeBaun, M Soucie, ... American journal of hematology 89 (8), 831-836, 2014 | 56 | 2014 |
| Hematologic outcomes after total splenectomy and partial splenectomy for congenital hemolytic anemia BR Englum, J Rothman, S Leonard, A Reiter, C Thornburg, M Brindle, ... Journal of pediatric surgery 51 (1), 122-127, 2016 | 52 | 2016 |
| Haemophilia A carriers experience reduced health‐related quality of life L Gilbert, A Paroskie, D Gailani, MR Debaun, RF Sidonio Haemophilia 21 (6), 761-765, 2015 | 52 | 2015 |
| Discussing investigational AAV gene therapy with hemophilia patients: a guide RF Sidonio Jr, SW Pipe, MU Callaghan, LA Valentino, PE Monahan, ... Blood reviews 47, 100759, 2021 | 51 | 2021 |
| An international survey to inform priorities for new guidelines on von Willebrand disease MA Kalot, M Al‐Khatib, NT Connell, V Flood, R Brignardello‐Petersen, ... Haemophilia 26 (1), 106-116, 2020 | 50 | 2020 |